• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCUTEK LTD GELWEAVE VALSALVA ANTE-FLO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCUTEK LTD GELWEAVE VALSALVA ANTE-FLO Back to Search Results
Model Number 734028/10ADP
Device Problem Device Operates Differently Than Expected (2913)
Patient Problems Fever (1858); Seroma (2069)
Event Date 06/03/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).A review of manufacturing and qc records confirmed that device has been manufactured to specification.Vascutek did not receive complaints for any other units from the complaint batches or any other units that were impregnated and sterilised at the same time as the complaint device.Endotoxin results for the complaint device were reviewed and they were within the limit.As the event was reported as fever and seroma 5-year similar events review covered all infection, seroma and fever complaints for all gelweave family product types which gave a low occurrence rate of 0.002% (complaints v sales).During review of vascutek's clinical evaluation report and relevant clinical papers for polyester vascular grafts, it was noted that seroma formation is a known and expected complication of this type of procedure.As a complaint device was not available physical analysis can't be completed.Vascutek now consider this event closed; however, the event type will continue to be tracked and trended through the complaint's monitoring system.If negative trend arises corrective actions may be considered at the time.
 
Event Description
Vascutek have received notification of the event that was described as 39-degree fever one week after the implant day.A seroma around the implanted graft was observed as well.Initially procedure was complete as usual.The patient is in clinical follow-up stage and is on the way to recovery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GELWEAVE VALSALVA ANTE-FLO
Type of Device
GELWEAVE VALSALVA ANTE-FLO
Manufacturer (Section D)
VASCUTEK LTD
newmains avenue
inchinnan business park
renfrewshire, scotland PA4 9 RR
UK  PA4 9RR
Manufacturer (Section G)
VASCUTEK LTD
newmains avenue
inchinnan business park
PA4 9 RR
UK   PA4 9RR
Manufacturer Contact
carolyn forrest
newmains avenue
inchinnan business park
UK   PA4 9RR
MDR Report Key6710368
MDR Text Key79928352
Report Number9612515-2017-00011
Device Sequence Number1
Product Code DSY
UDI-Device Identifier05037881121031
UDI-Public05037881121031
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K013022
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 06/28/2017,07/13/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date09/30/2021
Device Model Number734028/10ADP
Device Catalogue Number734028/10ADP
Device Lot Number15871214-9326
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Device Age10 MO
Event Location Hospital
Date Report to Manufacturer06/28/2017
Initial Date Manufacturer Received 06/28/2017
Initial Date FDA Received07/13/2017
Was Device Evaluated by Manufacturer? No
Date Device Manufactured09/14/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-